Susquehanna Fundamental Investments, LLC Agenus Inc Transaction History

Susquehanna Fundamental Investments, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.12 - $1.88 $66,137 - $111,015	-59,051 Reduced 26.86%	160,830 $181,000
Q1 2023 May 16, 2023	SELL	$1.45 - $2.95 $198,051 - $402,931	-136,587 Reduced 38.32%	219,881 $334,000
Q4 2022 Feb 14, 2023	BUY	$2.02 - $3.25 $444,109 - $714,532	219,856 Added 160.93%	356,468 $855,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $3.14 $117,353 - $188,004	-59,874 Reduced 30.47%	136,612 $280,000
Q1 2022 May 16, 2022	BUY	$2.35 - $3.47 $404,698 - $597,575	172,212 Added 709.45%	196,486 $483,000
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $495,833 - $974,686	-169,806 Reduced 87.49%	24,274 $78,000
Q3 2021 Nov 15, 2021	BUY	$4.98 - $6.63 $629,432 - $837,978	126,392 Added 186.73%	194,080 $1.02 Million
Q2 2021 Aug 11, 2021	BUY	$2.56 - $5.49 $173,281 - $371,607	67,688 New	67,688 $372,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Susquehanna Fundamental Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Susquehanna Fundamental Investments, LLC with notifications on news.